ADAMIS PHARMACEUTICALS CORP (ADMP)       0.2201  -0.01 (-4.3%)

0.2201  -0.01 (-4.3%)

US00547W2089 - Common Stock - After market: 0.2252 +0.01 (+2.32%)

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
5.97M2.21M16.53M22.11M15.09M
Non Recurring Items
1.37M5.01M-12.55M-320.00K-10.00K
Cost Of Goods
12.04M6.87M14.89M15.48M9.80M
Gross Profit
-6.07M-4.66M1.63M6.64M5.29M
Operating Expenses
54.63M27.41M38.87M35.66M44.74M
Operating Income
-60.70M-32.07M-37.24M-29.02M-39.45M
Interest Expense
-7.82M-7.54M390.00K1.85M90.00K
Income Before Taxes
-67.59M-34.60M-49.39M-27.50M-39.38M
Income Tax
N/A800.000.0010.00K-370.00K
Net Income
-79.33M-45.83M-49.39M-27.51M-39.01M
EBITDA
-59.22M-30.63M-33.63M-26.08M-36.35M
 
Per Share Data
EPS Diluted Total Ops
-0.54-0.32-0.64-0.52-1.00
Non GAAP EPS
-0.22-0.35-0.62-0.55-1.01
 
Statistics
Gross Profit Margin
-101.75%-211.14%9.86%30.03%35.06%
Profit Margin
-1329.19%-2074.91%-298.79%-124.42%-258.52%
Operating Profit Margin
-1016.99%-1451.97%-225.29%-131.25%-261.43%

All data in USD

Charts